Clinical Trials on 先天性鏡運動障害
Total 0 results
Nothing found
Sponsors and Collaborators
- Stannah Stairlifts
- Fogarty International Center of the National Institute of Health
- Advanced Life Solutions
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- Familien Hede Nielsens Fond
- Dr. Praveen B.H
- The Fred Hollows Foundation, Australia
- Custom Pharmaceuticals Limited
- Nestlé Health Science Belgium
- IN-JET APS
- UZ Leuven, campus Pellenberg (Belgium)
- Markham Stouffville Hospital
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Janssen (China) Research & Development Center
- Pedro Gamito
- JMI Laboratories
- Hospital Samaritano Paulista
- Physip S.A
- Prof. Jacques SCHRENZEL
- Hazelden Betty Ford Foundation
- View Full List
Medical Conditions
- Tay-Sachs Disease Ganglioside
- Psoriasis, Arthritic
- Childhood Langerhans Cell Histiocytosis
- Painless Hysteroscopy
- Multisystem Proteinopathy
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Predictors of Atrial Fibrillation Recurrences
- Chlamydophila Infections
- Skull Base Neoplasms
- Endocarditis Infective
- Spine Surgeries
- Epidemic Hemorrhagic Fever
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Fetus or Neonate Affected by External Version Before Labor
- Closure; Foramen Ovale
- Pulmonary Adenocarcinoma
- Fracture Dislocation of Cervical Spine
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Gullian Barre Syndrome
- Ewing's Family Tumors
- View Full List
Drug Interventions
- Palliative care group first-line scheme
- Semapimod
- Azelastine hydrochloride (BAYR9258)
- Cereport
- Esomeprazole 40mg before
- Neihulizumab
- Estradiol+Drospirenone
- High dose pantoprazole infusion
- Adriamycin
- Redifferentiation with retinoid acid
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Vehicle
- Glimepiride
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Qingkailing injection 40 ml
- Chemotherapeutic Agent
- Adapalene Gel 0.3%
- EFV +TVA
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- View Full List
CROs by country
- Contract Research Organizations in Belgium
- Contract Research Organizations in Canada
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Estonia
- Contract Research Organizations in Germany
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in Thailand
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uganda
- Contract Research Organizations in Uruguay
- Contract Research Organizations in Venezuela
- CRO list by country